http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#Head
http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#assertion
http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#provenance
http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#pubinfo
http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#assertion
http://purl.obolibrary.org/obo/DOID_5419
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_5419
http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00433
http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#association
http://www.w3.org/2000/01/rdf-schema#label
prochlorperazine maleate tablets are indicated for the control of severe nausea and vomiting prochlorperazine maleate tablets are also indicated for the treatment of schizophrenia prochlorperazine is effective for the short term treatment of generalized non psychotic anxiety however prochlorperazine maleate tablets are not the first drug to be used in therapy for most patients with non psychotic anxiety because certain risks associated with its use are not shared by common alternative treatments e g benzodiazepines when used in the treatment of non psychotic anxiety prochlorperazine maleate tablets should not be administered at doses of more than 2 mg per day or for longer than 12 weeks because the use of prochlorperazine maleate tablets at higher doses or for longer intervals may cause persistent tardive dyskinesia that may prove irreversible see warnings the effectiveness of prochlorperazine as treatment for non psychotic anxiety was established in 4 week clinical studies of outpatients with generalized anxiety disorder this evidence does not predict that prochlorperazine maleate tablets will be useful in patients with other non psychotic conditions in which anxiety or signs that mimic anxiety are found e g physical illness organic mental conditions agitated depression character pathologies etc prochlorperazine has not been shown effective in the management of behavioral complications in patients with mental retardation
http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB00433
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#provenance
http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#pubinfo
http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#sig
http://purl.org/nanopub/x/hasSignature
E6hMIG29/6lDx5bO4SyolCLTvAKjvCdP7Ui2i05uN/l5PfTFAfe7PDxMTR5sx6jcApVeylZ68G9bX8CcnTn1XNIFq+DFupr7WSsB7hzUmHarUTKCd0Dl7snETOCv/SU3zIL0hZAeTLmsYGlSGPvoOxXsxFNL58YwkwmkEokqVgM=
http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8
http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8
http://purl.org/dc/terms/created
2021-06-13T13:19:45.930+02:00
http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs